Project Grant HT94252510949
- This federal Project Grant award of $749,378.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support research by the Trustees of Indiana University, doing business as Indiana University, to investigate the systemic administration of STO-609 to prevent post-traumatic osteoarthritis in a translational porcine intraarticular fracture model. The project will run from August 1, 2025 to July 31, 2028. Indiana University, a prominent public...
- This $487,623 federal Project Grant, awarded on September 30, 2023 by the Defense Health Agency (DHA) under the Military Medical Research and Development CFDA program (12.420), supports research on the prevalence of neuropathic pain pathophysiology associated with ankle fracture. The award recipient is the Trustees of Indiana University, doing business as Indiana University, a major public research university with extensive expertise in biomedical sciences research. The project aims to advance...
- This $938,053 federal project grant awarded by the Defense Health Agency on September 30, 2023 under the Military Medical Research and Development program (CFDA 12.420) supports research on the prevalence of neuropathic pain pathophysiology associated with ankle fracture. The awardee, Trustees of Indiana University, will conduct this 4-year research project to advance scientific understanding and develop new treatment approaches for this condition affecting military service members and veterans....
- Trustees of Indiana University was awarded a $724,697 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to optimize muscle function in composite tissue injuries with segmental bone defects. The three-year award beginning May 1, 2023 will support Indiana University's research efforts to investigate medical solutions for battlefield injuries involving both soft tissue damage and bone loss. Through this funding,...
- The Trustees of Indiana University were awarded a $1.3 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 to prevent post-traumatic epilepsy by inhibiting the initiation of innate immune reaction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,924 Project Grant to the Trustees of Indiana University to support a 3-year research project titled "EARLY IMMUNOLOGIC PRECISION TYPING AT-RISK FRACTURES TO PREDICT NONUNION". The project aims to characterize the temporal immune/inflammatory biomarker profile in patients with open tibial fractures and develop a predictive model to guide decision-making for musculoskeletal...
- The Trustees of Indiana University were awarded a $3,930,678 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2024 to target replication stress in pediatric and young adult osteosarcoma. The Military Medical Research and Development program supports biomedical research to transform military and public health care through innovative solutions. This award...
- Trustees of Indiana University was awarded a $7.8 million project grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop pharmacotherapies for the treatment of hydrocephalus and associated conditions from September 1, 2023 through August 31, 2027. Under this award, Indiana University will leverage its expertise in biomedical research to investigate medical solutions targeted toward the military health system....
- The Defense Health Agency awarded a $435,782.00 Project Grant to the Trustees of Indiana University, doing business as Indiana University, under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from January 1, 2025 to December 31, 2027, will support research to explore the effects of tranexamic acid (TXA) on the pulmonary endothelium after thoracic trauma, with the goal of preserving endothelial integrity. As a prominent public research...
- The Defense Health Agency awarded a $1,489,868 Project Grant to the Trustees of Indiana University, doing business as Indiana University, under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from September 30, 2025 to September 29, 2029, will support the "OVARIAN CANCER ACADEMY: ADVANCING OVARIAN CANCER RESEARCH THROUGH MENTORSHIP, NETWORKING, AND COLLABORATIONS" initiative. The project aims to transform healthcare for military...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $7,195,717.00 to the Trustees of Indiana University for a research project titled "INTRA-ARTICULAR INJECTION OF AMOBARBITAL TO PREVENT POSTTRAUMATIC OSTEOARTHRITIS IN PATIENTS SUSTAINING SEVERE ANKLE TRAUMA." The award has an initial performance period from August 15, 2025 to August 14, 2030. The research aims to investigate the use of amobarbital injections to prevent the development of post-traumatic osteoarthritis in patients who have sustained severe ankle injuries. As a comprehensive research university, Indiana University will leverage its expertise in biomedical research to conduct this advanced medical investigation, which has the potential to transform healthcare for military service members and the broader public.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $7.2m | 8/7/25 |